Duvelisib was the next PI3K inhibitor authorized by the FDA, also determined by a stage III randomized trial.one hundred thirty The efficacy and safety profile of the drug seem comparable with Those people of idelalisib, Otherwise a little bit beneficial. Concerning different BTK inhibitors, there are plenty of merchandise in progress, but only aca